Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1
摘要:
Sixteen 3-(carboxymethyl)rhodanines, and twelve aminothiazoles as rhodanine-mimetics were designed, synthesized and tested as inhibitors of the Zmp1 enzyme from Mycobacterium tuberculosis (Mtb). Almost all rhodanines (5a-d, 5f-n, and 7a-b) exhibited Zmp1 inhibition with IC50 values in the range 1.3-43.9 mu M, whereas only aminothiazoles 12b and 12d proved active with IC50 values of 41.3 and 35.7 mu M, respectively. Structure-activity relationships (SAR) were coupled with molecular modeling studies to highlight structural determinants for Zmp1 inhibition. Moreover, rhodanines 5a and 5c induced 23.4 and 53.8% of Mtb growth inhibition in THP-1 infected cells, respectively, at the non-toxic concentration of 10 mu g/ml. This work represents a step forward in targeting Zmp1 by small molecules. (C) 2018 Elsevier Ltd. All rights reserved.
Solid-phase combinatorial synthesis of 5-arylalkylidene rhodanine
作者:Cheng Leng Lee、Mui Mui Sim
DOI:10.1016/s0040-4039(00)00866-2
日期:2000.7
Rhodanine-3-acetic acid was loaded on Wang resin or Rink amide resin. Alternatively, the thiocarbonyl-diimidazole-activated Wang amino acid resin or 2-chlorotrityl resin was reacted with methyl thioglycolate to yield the rhodanine moieties. It was then condensed at the C-5 active methylene with either aromatic aldehydes or aromatic ketones. 5-Arylalkylidene rhodanine was obtained upon resin cleavage. (C) 2000 Elsevier Science Ltd. All rights reserved.